who's who

3 Houston innovators to know this week

This week's roundup of Houston innovators includes Samantha Lewis of Mercury, Lydia Davies of Teamates, and Karen Leal of Insperity. Photos courtesy

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from sportstech to venture capital — recently making headlines in Houston innovation.

Samantha Lewis, principal at Mercury Fund

Samantha Lewis, principal at Mercury Fund, joins this week's episode of the Houston Innovators Podcast. Photo courtesy of Mercury Fund

It's not an easy time to be a startup founder, and Samantha Lewis, principal at Houston-based venture capital firm Mercury, knows that best. She joined the Houston Innovators Podcast to share what she's observed from the market — and how to navigate these uncertain times.

“We all know it’s turbulent market times. We’re unsure where the market is going, and when there’s uncertainty in the public markets, that puts uncertainty in the private markets,” Lewis says on this week's episode of the Houston Innovators Podcast. “What I’ve been spending the past two quarters doing is working with our portfolio companies to just make sure our balance sheets are bulked up for what’s to come in 2023.” Read more.

Karen Leal, performance specialist at Insperity

Time to think ahead, business owners. Here's what this expert thinks you need to prioritize. Photo courtesy

It's that time of year — the time to plan ahead for the next calendar year. Karen Leal, an expert at HR solutions company Insperity, wrote in a guest column her tips for small businesses and startups navigating the current market and planning ahead.

"While it is uncertain what lies ahead for businesses in 2023, leaders can prepare to face staffing challenges by choosing the best talent and creating a culture that shows employees that they are valued," she writes. Read more.

Lydia Davies, founder of TeeMates Golf and Teamates

Calling all sports fans. Image via LinkedIn

Lydia Davies, who launched TeeMates Golf last year, is back with another way for the athletically inclined to find likeminded individuals. Teamates, a new, Houston-based, multi-sport meetup app, connects like-minded sporty types who want to connect and run, hike, surf, or play golf, pickleball, and more.

“I have noticed more and more over the years that it is hard for adults to find friends, especially to find friends to play sports with,” said Davies in a press release. “Why not get active and use it as an icebreaker? Let us come out of the last few years healthier and happier by linking together to get outside and get active. Teamates makes it so easy to join a meetup with just one click.” Read more.

Trending News

Building Houston

 
 

You can now hop online and invest in this promising cell therapy startup. Photo via Getty Images

A clinical-stage company headquartered in Houston has opened an online funding campaign.

FibroBiologics, which is developing fibroblast cell-based therapeutics for chronic diseases, launched a campaign with equity crowdfunding platform StartEngine. The platform lets anyone — regardless of their net worth or income level — to invest in securities issued by startups.

The funding, according to a press release, will be used to support ongoing operations of Fibrobiologics and advance its clinical programs in multiple sclerosis, degenerative disc disease, wound care, extension of life, and cancer.

"We're excited to partner with StartEngine on this campaign. StartEngine has over 600,000 investors as part of their community and has raised over half a billion dollars for its clients," says FibroBiologics' Founder and CEO Pete O'Heeron, in the release.

"This is an exciting time at FibroBiologics as we continue progressing our clinical pipeline and developing innovative therapies to treat chronic diseases," he continues. "This new funding will fuel our growth in the lab and bring us one step closer to commercialization."

The campaign, launched this week, already has over 100 investors, at the time of publication, and has raised nearly $2 million, according to the page. The minimum investment is set at around $500, and the company's indicated valuation is $252.57 million.

In 2021, FibroBiologics announced its intention of going public. Last year, O'Heeron told InnovationMap on the Houston Innovators Podcast of the company's growth plans as well as the specifics of the technology.

Only two types of cells — stem cells and fibroblasts — can be used in cell therapy for a regenerative treatment, which is when specialists take healthy cells from a patient and inject them into a part of the body that needs it the most. As O'Heeron explains in the podcast, fibroblasts can do it more effectively and cheaper than stem cells.

"(Fibroblasts) can essentially do everything a stem cell can do, only they can do it better," says O'Heeron. "We've done tests in the lab and we've seen them outperform stem cells by a low of 50 percent to a high of about 220 percent on different disease paths."


Trending News